Geoffrey Wells

4.9k total citations · 1 hit paper
65 papers, 4.1k citations indexed

About

Geoffrey Wells is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Geoffrey Wells has authored 65 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 31 papers in Organic Chemistry and 8 papers in Pharmacology. Recurrent topics in Geoffrey Wells's work include Genomics, phytochemicals, and oxidative stress (22 papers), Synthesis and Biological Evaluation (15 papers) and Synthesis and biological activity (11 papers). Geoffrey Wells is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (22 papers), Synthesis and Biological Evaluation (15 papers) and Synthesis and biological activity (11 papers). Geoffrey Wells collaborates with scholars based in United Kingdom, United States and Singapore. Geoffrey Wells's co-authors include Malcolm F. G. Stevens, Tracey D. Bradshaw, Andrew D. Westwell, Nikolaos Georgakopoulos, Albena T. Dinkova‐Kostova, John D. Hayes, Michelangelo Campanella, Antonio Cuadrado, Ana I. Rojo and Otis C. Attucks and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Nature Reviews Drug Discovery.

In The Last Decade

Geoffrey Wells

63 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases

2019 1.0k citations Antonio Cuadrado, Ana I. Rojo et al. Nature Reviews Drug Discovery profile →

Peers

Geoffrey Wells

EPIDE

PHYSI

PHARM

Bhaskar C. Das United States

Hongwei Jin China

George Kokotos Greece

Jing Leng China

Liangren Zhang China

C.‐K. HWANG United States

Longqin Hu United States

Shasi V. Kalivendi India

Isabel Gómez‐Monterrey Italy

Richard C. Hartley United Kingdom

Bhaskar C. Das United States

Geoffrey Wells

1.4k ×0.6

798 ×0.5

341 ×0.8

EPIDE

224 ×0.9

PHYSI

172 ×0.8

PHARM

Citations per year, relative to Geoffrey Wells Geoffrey Wells (= 1×) peers Bhaskar C. Das

Countries citing papers authored by Geoffrey Wells

Since Specialization

Citations

This map shows the geographic impact of Geoffrey Wells's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geoffrey Wells with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geoffrey Wells more than expected).

Fields of papers citing papers by Geoffrey Wells

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geoffrey Wells. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geoffrey Wells. The network helps show where Geoffrey Wells may publish in the future.

Co-authorship network of co-authors of Geoffrey Wells

This figure shows the co-authorship network connecting the top 25 collaborators of Geoffrey Wells. A scholar is included among the top collaborators of Geoffrey Wells based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geoffrey Wells. Geoffrey Wells is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kozielski, Frank, et al.. (2025). Fragment-based drug discovery: A graphical review. PubMed. 9. 100233–100233.

Wells, Geoffrey, et al.. (2025). Basal activation of astrocytic Nrf2 in neuronal culture media: Challenges and implications for neuron-astrocyte modelling. PubMed. 9. 1533096256–1533096256. 1 indexed citations

Wells, Geoffrey, et al.. (2023). Small molecule and peptide inhibitors of βTrCP and the βTrCP–NRF2 protein–protein interaction. Biochemical Society Transactions. 51(3). 925–936. 9 indexed citations

Mak, Kit‐Kay, Shiming Zhang, Ola Epemolu, et al.. (2022). Synthesis and Anti‐Inflammatory Activity of 2‐Amino‐4,5,6,7‐tetrahydrobenzo[b]thiophene‐Derived NRF2 Activators. ChemistryOpen. 11(10). e202200181–e202200181. 9 indexed citations

Georgakopoulos, Nikolaos, Sandeep K. Talapatra, Dina Dikovskaya, et al.. (2022). Phenyl Bis-Sulfonamide Keap1-Nrf2 Protein–Protein Interaction Inhibitors with an Alternative Binding Mode. Journal of Medicinal Chemistry. 65(10). 7380–7398. 19 indexed citations

Fernández-Ginés, Raquel, et al.. (2022). The current status and future prospects for therapeutic targeting of KEAP1-NRF2 and β-TrCP-NRF2 interactions in cancer chemoresistance. Free Radical Biology and Medicine. 192. 246–260. 26 indexed citations

Harris, Sarah A., et al.. (2022). The C‐terminal head domain of Burkholderia pseudomalleiBpaC has a striking hydrophilic core with an extensive solvent network. Molecular Microbiology. 118(1-2). 77–91. 2 indexed citations

Wells, Geoffrey, Ángeles Martín‐Requero, Ana Martı́nez, et al.. (2022). Multitarget Hybrid Fasudil Derivatives as a New Approach to the Potential Treatment of Amyotrophic Lateral Sclerosis. Journal of Medicinal Chemistry. 65(3). 1867–1882. 17 indexed citations

Zhou, Jingyuan, Paul Stapleton, Francisco Humberto Xavier Júnior, et al.. (2022). Triazole-substituted phenylboronic acids as tunable lead inhibitors of KPC-2 antibiotic resistance. European Journal of Medicinal Chemistry. 240. 114571–114571. 5 indexed citations

10.

Suzuki, Takafumi, Jin Inoue, Tatsuro Iso, et al.. (2021). Molecular basis for the disruption of Keap1–Nrf2 interaction via Hinge & Latch mechanism. Communications Biology. 4(1). 576–576. 135 indexed citations

11.

Wells, Geoffrey, et al.. (2021). Atomic force microscopy—A tool for structural and translational DNA research. APL Bioengineering. 5(3). 31504–31504. 33 indexed citations

12.

Berta, Dénes, Andrei V. Pisliakov, Nadia Elghobashi‐Meinhardt, et al.. (2021). Modelling the active SARS-CoV-2 helicase complex as a basis for structure-based inhibitor design. Chemical Science. 12(40). 13492–13505. 10 indexed citations

13.

Edwards, Thomas L., Nicolas Foloppe, Sarah A. Harris, & Geoffrey Wells. (2021). The future of biomolecular simulation in the pharmaceutical industry: what we can learn from aerodynamics modelling and weather prediction. Part 1. understanding the physical and computational complexity of in silico drug design. Acta Crystallographica Section D Structural Biology. 77(11). 1348–1356. 3 indexed citations

14.

Cuadrado, Antonio, Ana I. Rojo, Geoffrey Wells, et al.. (2019). Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases. Nature Reviews Drug Discovery. 18(4). 295–317. 1034 indexed citations breakdown →

15.

Scurr, David J., Geoffrey Wells, Neil R. Thomas, et al.. (2019). <p>Protein Encapsulation of Experimental Anticancer Agents 5F 203 and Phortress: Towards Precision Drug Delivery</p>. International Journal of Nanomedicine. Volume 14. 9525–9534. 9 indexed citations

16.

Georgakopoulos, Nikolaos, Sandeep K. Talapatra, Jemma Gatliff, Frank Kozielski, & Geoffrey Wells. (2018). Modified Peptide Inhibitors of the Keap1–Nrf2 Protein–Protein Interaction Incorporating Unnatural Amino Acids. ChemBioChem. 19(17). 1810–1816. 33 indexed citations

17.

Georgakopoulos, Nikolaos, Geoffrey Wells, & Michelangelo Campanella. (2017). The pharmacological regulation of cellular mitophagy. Nature Chemical Biology. 13(2). 136–146. 257 indexed citations

18.

Georgakopoulos, Nikolaos, Jemma Gatliff, & Geoffrey Wells. (2016). Development of Keap1-interactive small molecules that regulate Nrf2 transcriptional activity. Current Opinion in Toxicology. 1. 1–8. 8 indexed citations

19.

Bertrand, Hélène, et al.. (2011). Peptide inhibitors of the Keap1–Nrf2 protein–protein interaction. Free Radical Biology and Medicine. 52(2). 444–451. 129 indexed citations

20.

Wells, Geoffrey, Angela Seaton, & Malcolm F. G. Stevens. (2000). Structural Studies on Bioactive Compounds. 32. Oxidation of Tyrphostin Protein Tyrosine Kinase Inhibitors with Hypervalent Iodine Reagents. Journal of Medicinal Chemistry. 43(8). 1550–1562. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact